Trillions
Trillions

How Leveraged ETFs Became Wall Street's New Obsession

The confluence of single-stock ETFs and leverage has reached a fever pitch this year. Products tied to companies like SpaceX, Micron and SK Hynix are proliferating, attracting billions of dollars from traders — and raising concerns they're beginning to influence the very stocks they're mea

Featured Speakers

Bloomberg Host

Episode Summary

Executive Summary: The episode debates leveraged ETFs, especially new single-stock 2x/3x products, weighing their popularity and trading utility against concerns they can distort smaller underlying names. Guests argue these products are mostly used as short-term speculation tools, not long-term investments, while acknowledging that in some thinly traded stocks they can create real “tail wagging the dog” effects. Overall, the discussion frames leverage ETFs as a growing but niche part of modern market behavior.

Main Topics: Leveraged ETFs as trading tools (Priority: 5/5): The hosts argue leveraged ETFs are primarily designed for short-term speculation and tactical trading, likening them to a casino or “cheap thrill” rather than long-term investments. They emphasize that many users understand the risks and trade them actively. Single-stock ETF market impact (Priority: 5/5): The conversation distinguishes broad index leveraged ETFs from single-stock leveraged ETFs, with concern that some small- and mid-cap names can be affected by ETF flows, options activity, and rebalancing. These are the main examples of potential market distortion. Growth in assets, volume, and product launches (Priority: 4/5): Leveraged ETFs have grown into a major trading category, with more than $200 billion in assets and very high daily turnover. The launch of single-stock products since 2022 has accelerated issuer competition and product proliferation. Risk, volatility, and decay (Priority: 5/5): Participants explain that leverage can amplify gains in trending markets but can also create volatility decay and severe losses over time. They stress that investors need to monitor these products daily and take profits when appropriate. Issuer competition and product economics (Priority: 3/5): Issuers are launching more products because the category is lucrative, with high fees and the potential for one successful product to become very profitable. The discussion highlights firms like Direxion, ProShares, GraniteShares, Tuttle, REX, and Corgi. Regulatory and structural guardrails (Priority: 4/5): The guests discuss why 3x or 4x single-stock ETFs are not permitted and why banks, swap counterparties, and risk controls already limit exposure. They suggest some single-stock products may need tighter guardrails or clearer labeling. Leverage as a sentiment barometer (Priority: 3/5): The long-to-short ratio and product growth are presented as indicators of market exuberance, especially in tech. The guests suggest leverage ETF usage reflects broader bullish sentiment rather than being the main driver of market moves.

Key Arguments: Leveraged ETFs are mostly used by traders seeking daily exposure and not by long-term investors, so high volume is not inherently alarming. The broader leverage ETF universe is unlikely to pose systemic risk because its notional size is still small relative to the total equity market. A handful of single-stock ETFs on thinly traded names may distort price action enough to qualify as “tail wagging the dog.” Most of the concern should focus on small or retail-heavy names such as Bitmine, MicroStrategy, and Oklo rather than the entire category. Index leverage ETFs appear healthier and more disciplined than single-stock products, with investors often taking profits and using short products as hedges. The biggest danger is volatility decay and bad timing, not the product structure itself; many users know to trade in and out quickly. Leverage ETF growth is partly a byproduct of a strong bull market, especially in tech and semiconductors, where compounding can work in favor of holders. Issuers keep launching leveraged products because the economics are attractive and competition in plain-vanilla ETF markets is brutal. Regulators already restrict 3x and higher single-stock leverage, which helps contain the worst-case scenarios. Some single-stock products may need more explicit warnings or “red light” style labeling to signal that they are high-risk trading tools.

Data Points: Total leverage ETF assets: $200 billion - Estimated assets across the leveraged ETF category discussed by the hosts. Leveraged ETF trading volume share: 13% of all ETF trading - Used to show these products trade far more actively than their asset share suggests. Leveraged ETF asset share: 1% of ETF assets - Illustrates the mismatch between assets and trading activity. Average daily trading volume: $50 billion per day - Stated for leveraged ETFs overall, up sharply from pre-COVID levels. Growth in trading volume since pre-COVID: 10x - Hosts note volume is roughly ten times higher than before COVID. Profit generated for users: $65 billion - Estimated cumulative profits generated by leveraged ETFs overall for investors. Single-stock leverage ratio: 38 to 1 - Ratio cited for single-stock levered products when measured by long exposure versus inverse exposure. Single-stock leverage ratio including leverage: 45 to 1 - A broader leverage-adjusted ratio cited by James Seyffart. Whole-space long-to-short ratio: 19 to 1 - Used as a sentiment indicator across all leveraged products. Pre-2022 long-to-short ratio peak: 5 to 1 - Historical comparison showing the current market is far more tilted toward long leverage. Number of leveraged ETFs: Over 750 - Approximate total count of leverage ETFs in the market. Single-stock leveraged long ETFs: 440 - Count of single-security leveraged long products mentioned by James Seyffart. Single-stock leveraged short ETFs: 56 - Count of single-security leveraged short products mentioned by James Seyffart. Single-stock ETFs with under $25 million in assets: 250 - Shows many products are small or inactive despite the large number of launches. New single-stock ETF era start: June 2022 - Referenced as the beginning of the single-stock leveraged ETF wave. TQQQ lifetime return: 38,000% - Example used to show how a leveraged index ETF can produce huge gains in a strong bull market. TQQQ profits for investors: $50 billion - Cited as cumulative money made by investors in that product. NVDL flows: About $1.5 billion - Todd Sohn says NVIDIA’s strength helped assets grow far beyond initial flows. NVDL assets: $6 billion - Illustrates how underlying stock performance can magnify leveraged ETF AUM. Corgi existing ETF count: 160 - Number of ETFs already on the market from the issuer. Corgi filed ETFs: 350-360 - Number of additional filings mentioned, indicating rapid expansion plans. Potential Corgi product count: Upwards of 500 - Projected total if filings are launched, within roughly one year of existence.

Pivotal Quotes: "We haven't given it the full episode treatment. Leverage, also known as X. XXX." — Joel Weber: Opening framing of the episode’s focus on leveraged ETFs. "There is a little bit of the tail wagging the dog here in names." — James Seyffart: On single-stock leveraged ETFs affecting smaller underlying stocks. "I equate it to whiskey and fast food. It's not healthy, but it does, you know, it'll make you feel good for a minute." — Eric Balchunas: His analogy for leveraged ETFs as a speculative trading indulgence.

Implications: Leveraged ETFs are likely to keep growing, especially in tech and single stocks, but investors should treat them as short-term, high-risk tools. Expect more issuer competition, more thematic leverage, and possible guardrails or label changes for thinner names.

🔓 Sign Up for Unlimited Episode Search

About Trillions

Money goes where it's treated best. That simple truth is a big reason why more and more money—trillions, in fact—flows into a powerful, low-cost tool that's quietly transformed investing in recent years. Exchange-traded funds, or ETFs, let you invest in everything from the stock market to gold like never before. This biweekly podcast will demystify them—and delight you in the process.

View all episodes from Trillions